New infrared scanner aims to spot breast cancer before tumors form

NCT ID NCT06045572

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called VTM that uses infrared light to look for early signs of breast cancer, possibly before a lump appears. Researchers will compare VTM scans with standard mammograms in 120 women with breast cancer. The goal is to see if VTM can find tumors and blood vessel changes earlier and more accurately.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
VTM examination (non-ionizing infrared imaging device) and breast biopsy
What this could lead to
If successful, this could provide a new, radiation-free way to detect breast cancer earlier, potentially before a tumor is visible on mammography.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The device's accuracy compared to standard methods is unproven, and it may not improve outcomes or replace existing screening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.